File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: The use of estrogen in the treatment of Parkinson's disease

TitleThe use of estrogen in the treatment of Parkinson's disease
Authors
Issue Date2001
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/parkreldis
Citation
The 5th International Symposium on the Treatment of Parkinson's Disease, Kobe, Japan, 30 September-1 October in 2000. In Parkinsonism & Related Disorders, 2001, v. 8 n. 2, p. 133-137 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/163552
ISSN
2015 Impact Factor: 3.794
2015 SCImago Journal Rankings: 1.488
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorTsang, KLen_US
dc.contributor.authorJiang, Hen_US
dc.contributor.authorRamsden, DBen_US
dc.contributor.authorHo, SLen_US
dc.date.accessioned2012-09-05T05:37:22Z-
dc.date.available2012-09-05T05:37:22Z-
dc.date.issued2001en_US
dc.identifier.citationThe 5th International Symposium on the Treatment of Parkinson's Disease, Kobe, Japan, 30 September-1 October in 2000. In Parkinsonism & Related Disorders, 2001, v. 8 n. 2, p. 133-137en_US
dc.identifier.issn1353-8020en_US
dc.identifier.urihttp://hdl.handle.net/10722/163552-
dc.languageengen_US
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/parkreldisen_US
dc.relation.ispartofParkinsonism & Related Disordersen_US
dc.subject.meshAntiparkinson Agents - Therapeutic Useen_US
dc.subject.meshCorpus Striatum - Drug Effectsen_US
dc.subject.meshDopamine - Metabolismen_US
dc.subject.meshEstrogens - Therapeutic Useen_US
dc.subject.meshFemaleen_US
dc.subject.meshHormone Replacement Therapyen_US
dc.subject.meshHumansen_US
dc.subject.meshMenstrual Cycleen_US
dc.subject.meshMethyltransferases - Metabolismen_US
dc.subject.meshNeuroprotective Agents - Therapeutic Useen_US
dc.subject.meshParkinson Disease - Drug Therapy - Physiopathologyen_US
dc.subject.meshSex Characteristicsen_US
dc.subject.meshSubstantia Nigra - Drug Effectsen_US
dc.titleThe use of estrogen in the treatment of Parkinson's diseaseen_US
dc.typeConference_Paperen_US
dc.identifier.emailHo, SL:slho@hku.hken_US
dc.identifier.authorityHo, SL=rp00240en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S1353-8020(01)00027-Xen_US
dc.identifier.pmid11489678-
dc.identifier.scopuseid_2-s2.0-0034899543en_US
dc.identifier.hkuros82353-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0034899543&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume8en_US
dc.identifier.issue2en_US
dc.identifier.spage133en_US
dc.identifier.epage137en_US
dc.identifier.isiWOS:000171220400009-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridTsang, KL=7201554745en_US
dc.identifier.scopusauthoridJiang, H=36077295400en_US
dc.identifier.scopusauthoridRamsden, DB=7102612805en_US
dc.identifier.scopusauthoridHo, SL=25959633500en_US
dc.customcontrol.immutablesml 160303 - amend-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats